5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole
C24H27FN4O2 — CID 144923098
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole
5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole (PubChem CID 144923098) has the molecular formula C24H27FN4O2 and a molecular weight of 422.50 g/mol. Its IUPAC name is 5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 144923098 |
| Molecular Formula | C24H27FN4O2 |
| Molecular Weight | 422.50 g/mol |
| Exact Mass | 422.21 |
| IUPAC Name | 5-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]-3-[2-(4-fluorophenyl)propan-2-yl]-1,2,4-oxadiazole |
| SMILES | CC(C)(c1ccc(F)cc1)c1noc(N2CCN(Cc3ccc4c(c3)CCO4)CC2)n1 |
| InChI | InChI=1S/C24H27FN4O2/c1-24(2,19-4-6-20(25)7-5-19)22-26-23(31-27-22)29-12-10-28(11-13-29)16-17-3-8-21-18(15-17)9-14-30-21/h3-8,15H,9-14,16H2,1-2H3 |
| InChIKey | KTMWLJUVEVOFRY-UHFFFAOYSA-N |
| XLogP | 3.79 |
| TPSA | 54.63 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.50 |
| LogP ≤ 5 | 3.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144923098 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.